Vertex Pharmaceuticals Inc $90.22

up +1.23


22/8/2014 04:00 PM  |  NASDAQ : VRTX  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get VRTX Trend Analysis - it has underperformed the S&P 500 by 5%

Partner Headlines

  1. GW Pharma, Insys Face Off In Cannabis Drug Space

    IBD
  2. Stocks Gain, Techs Take Lead; Autohome, BitAuto Top IBD 50

    IBD
  3. Vertex Is Poised For An Earnings Breakout

    Benzinga
  4. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD
  5. Analyst Concerns On Vertex's Approved Drug

    Benzinga
  6. Benzinga's Top Downgrades

    Benzinga
  7. Vertex Soars On Drug Study

    IBD
  8. Utility Sector Rises; Elizabeth Arden Shares Slide Over 3.6%

    Benzinga
  9. Micron Gains On Upbeat Earnings; Elizabeth Arden Shares Slide

    Benzinga
  10. Nasdaq Hits 14-Year High; Facebook Breaks Out

    IBD
  11. Deutsche Bank Reiterates Buy on Vertex Pharmaceuticals Following Press ...

    Benzinga
  12. Vertex Cystic Fibrosis Success Quells Street's Doubts

    IBD
  13. Bernstein Weighs In On Vertex Move

    Benzinga
  14. Benzinga's Volume Movers

    Benzinga
  15. Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Misses ...

    Benzinga
  16. Stocks Hitting 52-Week Highs

    Benzinga
  17. Morning Market Movers

    Benzinga
  18. Stocks Poised For Soft Start; Vertex Rockets In Premarket

    IBD
  19. Why Are Vertex Pharmaceuticals Up More Than 50 Percent?

    Benzinga
  20. Benzinga's Top #PreMarket Gainers

    Benzinga
  21. Indexes End With Small Gains; Tesla Drives Higher

    IBD
  22. Vertex Shares Hit Hard On Trial Concerns

    Benzinga
  23. Benzinga's Top #PreMarket Losers

    Benzinga
  24. Health Care Sector in an Upward Climb in June

    GuruFocus
  25. For The Record

    IBD
  26. Vertex Pharmaceuticals

    IBD
  27. Nasdaq Up 1.7%; Bed, Bath & Beyond Sinks After Hours

    IBD
  28. House Probe Of Gilead's Sovaldi Price Hits Biotechs

    IBD
  29. Gilead Pricing Probed By House; Biotech Stocks Drop

    IBD
  30. Dow, S&P 500 Up, Nasdaq Slips; Drugmakers Falling Hard

    IBD
  31. BioMed Realty Trust Leases Space To Life Science Firms

    IBD
  32. Stocks Open Higher, Turn Mixed After Employement Report

    IBD
  33. Revenue Growth: Focus On Healthcare Stocks

    YCharts
  34. Enanta Joins Big Leagues With Hepatitis C Drug

    IBD
  35. Vertex drug trial results mixed

    IBD
  36. Vertex Cystic Fibrosis Trial Has Good, Bad News

    IBD
  37. Benzinga's Top #PreMarket Losers

    Benzinga
  38. Vertex Pharma Says Phase 3 Study Results of Ivacaftor Did Not Meet Primary ...

    Benzinga
  39. Trade Idea of the Day: Short Vertex

    Benzinga
  40. Nasdaq Leads Stocks Higher; Archer Daniels Deal Blocked

    IBD
  41. US Stock Futures Edge Lower Ahead Of FOMC Minutes, Economic Data

    Benzinga
  42. Vertex Sells INCIVO Product Royalty Rights to Janssen Pharmaceutica for ...

    Benzinga
  43. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    Benzinga
  44. Vertex Drug, Fastest Blockbuster, Quickly Fading

    YCharts
  45. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, ...

    Benzinga
  46. Vertex Announces Oral Selective JAK3 Inhibitor VX-509 Shows Statistically ...

    Benzinga
  47. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  48. J&J Buys Glaxo Drug In Hunt For All-Oral HCV Therapy

    IBD
  49. Stocks Post Broad, Soft Losses; Amgen, Vertex Drag On Nasdaq

    IBD
  50. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)

    Benzinga
Trading Center